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The primary immunization of mice with sheep erythrocytes (SRBC) I leads to the 
stimulation  in  the  spleen  of both bone marrow-derived lymphocytes (B  cells)  and 
thymus-derived lymphocytes (T cells). 
The cellular  events  underlying the  stimulation  of B  cells  have  been  extensively 
studied both in vivo (for review see  1)  and in vitro  (2-6).  SRBC-specific precursor 
cells are selectively stimulated by the antigen with the help of T  cells which are also 
specific  for the antigen.  These precursors rapidly  divide  and  differentiate into cells 
secreting  specific  antibody which generally  appear  in  the  spleen  with  exponential 
kinetics. The role of cellular proliferation in this process has been established with a 
number of antimetabolites which inhibit either mitosis  (7)  or DNA synthesis (8-10) 
and with lethally high levels of tritiated thymidine (3). 
The stimulation of T  cells  is not as well understood. There is a  rapid increase in 
specific  helper T  cell activity in the spleens  of SRBC-immunized mice (11-13). This 
"priming" of T  cell activity differs from the response of B cells  to antigen in that it 
can be accomplished with very low antigen dose which fails  to elicit antibody produc- 
tion  (12,  14),  is  not sensitive  to suppression  by passively  administered  anti-SRBC 
serum  (12,  15),  and reaches maximal levels  within 3 days of immunization (13).  In 
addition to cellular proliferation, roles in the process of priming have been attributed 
to both the antigen-directed  "homing" of specific  T  cells  to the spleen  (16)  and the 
activation of inactive T  cells by the antigen (17). 
We have studied the kinetics of helper T  cell priming by SRBC in relation to 
the response of B  cells using a  quatitative  in vitro technique for the assay  of 
helper activity (13,  18). Experiments utilizing the inhibitor of mitosis,  vinblas- 
fine,  indicate  that,  although  the  priming  of helper  activity precedes  the  ap- 
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pearance of antibody-producing cells by as much as 7 day, T  cells lag at least  1 
day behind B  cells in the onset or  cellular proliferation.  The evidence  suggests 
that  the T  cells whose  activity increases during priming  and those which  help 
in  the  initiation of  the  primary  B  cell  response  may  be  two  different  popula- 
tions. 
Materials a~d Methods 
Mice.--8-12-wk  old  hybrid mice  (BDF1)  raised  in  our  own  laboratory from  C57BL/6 
female X  DBA/2 male were used in all experiments. 
Antigens.-  Sheep  erythrocytes  (SRBC)  and  horse  erythrocytes  (HRBC)  were  obtained 
from the Colorado  Serum Co.,  Denver,  Colo.  Trinitrophenylated  (TNP)  erythrocytes were 
prepared by the method of Rittenberg and Pratt  (19)  as modified by Kettman and Dutton 
(20). 
Imm~misalions.IIn  vivo immunizations were by tail vein injection in 0.2 ml of balanced 
salt solution  (BSS). Three doses of antigen were used  (14):  (a)  High: 2 X  108 SRBC.  This 
dose gives an optimal antibody response but relatively poor T  cell priming.  (b) Intermediate: 
2  X  107 SRBC. This dose gives both a good antibody response and T  cell priming.  (c) Low: 
2 X  10 6  SRBC.  This  dose gives optimal T  cell priming but a  poor  antibody response.  In 
vitro immunizations were 2  X  106 erythrocytes in 0.05 ml of BSS. 
Cultures.--Spleen cell suspensions were cultured  by the methods of Dutton  and Mishell 
(2)  as modified by Kettman and Dutton  (20)  for TNP-erythrocyte antigens. The cell con- 
centration in all experiments was  10  7  spleen  cells per culture. 
Drugs.--Vinblastine  sulfate  was  purchased  from  Eli  Lilly  and  Co.,  Indianapolis,  Ind. 
Stocks of  1 mg/ml BSS were prepared.  The drug was administered intraperitoneally in 0.3 
ml of BSS. 
Assay  of Antibody-Producing Cells.  Cells  producing  antibody  specific  for  erythrocyte 
determinants were  enumerated  by  the  Jerne hemolytic plaque  assay  (21),  as  modified  by 
Dutton and Mishell (2). 
TNP-specific  antlbody-producing cells  were  assayed  by  the  modification of  Rittenberg 
and Pratt (19) as further modified by Kettman and Dutton (20) using TXP coupled to HRBC 
in the plaque assay. In each assay a parallel determination was made with TXP-free HRBC. 
This HRBC  "background" was  subtracted  from  the  value obtained with TNP-HRBC  to 
calculate  the  number of TNP-specific  plaque forming cells  (PFC).  This  correction seldom 
amounted to more than 5%. 
Assay for Thymus-Derived Helper Call A cliz'ity. -The helper activity of T  cells was assayed 
by a modification of the techniques of Kettman and Dutton (5, 13, 20).  Details of the method 
are published in the preceding paper in this series  (18).  Briefly, helper activity was equated 
with the ability of spleen cells from mice primed with SRBC  to enhance the in vitro anti- 
TNP  response of normal spleen cells  when immunized with  TNP-SRBC.  Tritrations were 
performed  in which  a  varying number of  primed  cells  were  added  to  normal  spleen  cells 
keeping the total cell number per culture constant at  10  7.  The enhancement of the anti-TNP 
response above that of normal cells alone in units of anti-TNP PFC per 106 recovered culture 
cells on day 4, of culture was plotted vs.  the number of primed cells per culture.  The best 
straight line was fit to the data and the slope of this titration line taken as a measure of the 
helper activity in the primed cells in units of anti TNP  PFC per 106 recovered cells per 106 
primed cells. 
RESL'LTS 
The Ki~etics of the Priming of Helper T  Cell Activity and the A~li-SRBC PFC 
Response.--The spleens of mice were examined at various times after imnmniza- JOHN  W.  KAPPLER  AND  MICHAEL  HOFFMANN  1327 
tion with SRBC for anti-SRBC PFC and for SRBC-specific helper activity. The 
results are shown in Fig. 1. At either a high (2 X  l0 s) or intermediate (2 X  10 7) 
dose of  SRBC,  PFC  begin  to appear  in the  spleen at  about  1 day  after im- 
munization and increase exponentially until a maximum is reached after 4 days. 
The increase in helper activity after an intermediate (2 X  10  7) or low (2  X  10 6) 
dose of SRBC is evident by day 1, substantial by day 2, and nearly maximal by 
day 3. 
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FIG.  1.  Kinetics of the priming of SRBC-specific helper T  cells and the development of 
anti-SRBC PFC. Results of three experiments are shown. Groups of three mice were immu- 
nized with 2 X  106  (triangles),  2 X  107  (circles),  or  2 X  l0  s  (squares)  SRBC  at  various 
times before sacrifice.  At sacrifce spleens were assayed for anti-SRBC PFC  (closed symbols) 
and/or for the presence of SRBC-specific helper activity (open symbols) as described in Mate- 
rials  and  Methods.  Anti-SRBC  PFC  are  the geometric means of  determinations made  on 
individual spleens within each group. Helper activity was determined using several concen- 
trations of  a  pooled  suspension of  the  spleens of  each group.  For  ease of  comparison  the 
results are normalized to  100% at day 4. The actual anti-SRBC PFC response on day 4  in 
PFC/106  spleen cells were: 2 X  10  s SRBC,  2,150; 2 X  107  SRBC,  569.  The actual helper 
activities on  day 4  in  anti-TNP  PFC/106  recovered culture cells/106 primed  spleen cells 
were: 2  X  106 SRBC,  1,381;  2 X  107 SRBC, 405. 1328  PROLIFERATIVE  RESPONSE  O:F  T  CELLS  AND  B  CELLS 
The Effect of Vinblastine on the Priming of Helper T Cell Activity and the Anti- 
SRBC PFC Response.--In order to study the role of cellular proliferation in the 
priming of helper activity the mitotic inhibitor, vinblastine, was used. Vinblas- 
fine was given to mice at various times after immunization with SRBC. The 
spleens of these animals were then examined for anti-SRBC PFC and SRBC- 
specific helper activity on day 4 after immunization, a time when both are maxi- 
mal in untreated controls. The results are shown in Fig. 2. When given with the 
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FIG. 2.  Effect of vinblasdne on the priming of SRBC-specific helper T  cells and the de- 
velopment of anti-SRBC  PFC.  The results of four experiments are shown. In each experi- 
ment groups of four animals were given 2  X  I0  ? SRBC  (day 0)  and a  varying dose of vin- 
blastine on either day 0  (exp. a),  day 1  (exp. b), day 2  (exp. c), or day 3  (exp. d). On day 4 
the animals were sacrificed and their spleens assayed for anti-SRBC  PFC  (e)  and SRBC- 
specific helper activity  (©)  as in Fig.  1. Results are shown as the percent  of  the  responses 
in the control animals receiving no vinblastine. The mean and-SP,  BC PFC responses in  the 
control groups in PFC/106 spleen cells were: exp. 2, 545; exp. b, 348; exp. c,  170;  and exp. d, 
194,. The helper activity in the control groups in anti-TNP PFC/106 recovered culture cells/ 
10 ~ primed spleen cells were: exp. a, 525; exp. b, 918; exp. c, 472; and exp. d,  1,210. JOHN  W.  KAPPLER  AND  MICHAEL  HOFFMANN  1329 
antigen (day 0) doses of greater than 100/~g of vinblastine suppress the appear- 
ance of anti-SRBC PFC but have no effect on the priming of helper activity 
(Fig. 2 a). Similar results are obtained when the vinblastine is given 1 day after 
the  antigen except that  the  anti-SRBC  PFC  response is inhibited  by much 
smaller doses of vinblastine  (Fig. 2 b). When given 2 days after the  antigen, 
vinblastine  inhibits  the  anti-SRBC  PFC  response  at  relatively small  doses, 
whereas doses above 50 #g inhibit the priming of helper activity (Fig.  2  c). 
Finally when given 3 days after the antigen both the anti-SRBC PFC response 
and the priming of helper activity are suppressed equally well by vinblastine 
(Fig. 2 d). 
The data in Fig. 2 suggest that helper T  cells lag behind B cells in the onset 
of cellular proliferation after immunization. This point is better seen in Fig. 3 in 
which some data from Fig. 2 and data from a number of other experiments are 
plotted as the percent of the anti-SRBC PFC response or helper activity re- 
maining on day 4 vs. the time after immunization at which a dose of 150/zg of 
vinblastine is given. At an immunizing dose of either 2 X  107 or 2 X  l0  s the 
anti-SRBC PFC  response is inhibitable by vinblastine immediately after im- 
munization. On the other hand the priming of helper T  cell activity cannot be 
inhibited by vinblastine until about 1½ days after immunization. 
Specificity  of  the  Effect  of  Vinblastine.--In  order  to  interpret  the  results 
shown above it was necessary to show that the effect of vinblastine was specific 
for the immunizing antigen, The specificities of the effect on T  cells and B cells 
are shown in Table I and Table II, respectively. 
In Table I two groups of four mice (A and B) were given SRBC on day 0 and 
a non-crossing-reacting antigen, TRBC, on day 2. On day 2.5,  150 #g of vin- 
blastine was given to group B to suppress the priming of SRBC-specific helper 
activity. On day 5 the spleens of both groups were assayed for both SRBC- and 
TRBC-specific helper  activity.  The results  show  that  as  expected only the 
priming of SRB C-specific helper activity is inhibited by the vinblastine. 
In Table II groups of eight mice were given SRBC on day 0 followed by either 
0, 50, or 100/~g of vinblastine on day 1. On day 2 all mice were given a second 
non-cross-reacting antigen, TNP-TRBC. On day 4 the spleens of half of each 
group were assayed for anti-SRBC PFC and on day 6 the spleens of the second 
half assayed for anti-TNP PFC.  (The anti-TNP response was assayed rather 
than the anti-TRBC response, since TRBC are poor indicators in the plaque 
assay.) The results show that only the PFC response to SRBC is suppressed by 
the vinblastine. 
DISCUSSION 
We have studied the kinetics of the response to the antigen SRBC in mouse 
spleen of both helper T  cells and the B cell precursors of PFC. After a primary 
immunization with SRBC anti-SRBC PFC began to appear in the spleen after 
1 day and increased exponentially until about day 4. The priming of helper T 1330  PROLIFERATIVE  RESPONSE  OF  T  CELLS  AND  B  CELLS 
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FIG. 3.  Kinetics of the proliferative response of T  cells and B  cells to SRBC. The results 
of a number of experiments are shown. In each experiment groups of three to four mice were 
given either 2  X  106  (triangles),  2 X  107  (circles),  or  2 X  10  s  (squares)  SRBC  on day  0. 
At various times afterwards  150 ~g of vinblastine was administered. On day 4  the animals 
were sacrificed and their spleens assayed for anti-SRBC PFC (closed symbols) and/or SRBC- 
specific  helper activity (open symbols) as in Fig.  1.  Results are reported as  the  percent  of 
the responses in groups of control mice which received no vinblastine. The mean anti-SRBC 
PFC responses in the control groups varied from 76 to 1,210 PFC/106 spleen ceils in the vari- 
ous experiments. The SRBC-specific helper activity in the control groups varied from 348 
to  1,992  anti-TNP PFC/106  recovered culture cells/106 primed spleen cells  in  the various 
experiments. 
cell  activity  was  more  rapid  with  maximal  activity  reached  by  about  day  3. 
These results are generally in agreement with those of others (2,  12,  13, 22). We 
also compared the role of cellular proliferation in the responses of these two cell 
types and found that they show quite different kinetics. Using sensitivity to the 
mitotic  inhibitor,  vinblastine,  as  an  indicator  of  proliferation,  we  determined JOHN  W.  KAPPLER  AND  MICHAEL HO~I~MANN 
TABLE I 
Speci~city of the Effect of Vinblastine  on T  Cells 
1331 
Protocol 
Group*  First antigen  Second antigen  Vinblastine 
Day 0  Day 2  Day 2.5 
Assay for 
helper aetivity:~ 
Day 5 
SRBC-  TRBC- 
specific  specific 
(PFC/IO o  (PFC/tOo 
per 106)  per l0  s  ) 
A  2 X  106 SRBC  8 X  105 TRBC  --  304  244 
lOO%§  ioo% 
B  2 X  106 SRBC  8 X  105 TRBC  150 #g  50  258 
16%  11o% 
* Four mice per group. 
:~ Spleens pooled within each group before assay. 
§ Percent of group A. 
TABLE II 
Specificity  of the Effect of Vinblastine  on B  Cells 
Protocol 
Anti-SRBC  Anti-TNP re- 
Group  First antigen  Vinblastinc  Second antigen  response PFC/10 s  sponse PFC/106 
Day 0  Day 1  Day 2  Day 4  Day 6 
A  2 X  107 SRBC  --  2 X  107  377*  146 
(212-677)$  (118-177) 
TNP-TRBC  100%§  100% 
B  50/2g  2 X  107  111  166 
(77-161)  (131-193) 
TNP-TRBC  29.5%  114% 
C  2 X  107 SRBC  100 #g  2 X  10  7  12.4%  203% 
(7.4-23.9)  (157-248) 
"[NP-TRBC  3.3%  139% 
2 N  107 SRBC 
* Geometric mean of determinations in four animals. 
:~ Range. 
§ Percent of group A. 
that B  cells begin to divide under antigen stimulation at least one day before 
helper T  cells. The peak of  sensitivity to vinblastine of the B  cell response is 
between day 1 and day 2 when PFC are assayed on day 4. The peak of sensi- 
tivity of the T  cell response under the same conditions does not occur until be- 
tween day  2  and day 3.  We  obtained similar results with  a  number of  im- 
munizing doses. 
We had to consider several trivial explanations for our results. It might have 1332  PROLIFERATIVE  RESPONSE  OF  T  CELLS  AND  B  CELLS 
been that the sensitivity of T  cells and B  cells to vinblastine was due to some 
nonspecific effect on the drug on all cells in the spleen, both responding and non- 
responding, or perhaps, in the case of T  cells,  the effect of vinblastine may have 
been indirectly due  to  the  carry-over of the  drug  into  the  culture  assay for 
helper activity. The necessity for the proper scheduling of the administration 
of antigen and vinblasfine for the maximal effect (see Fig. 3) made these possi- 
bilities  seem unlikely;  however,  they were eliminated  by the  control  experi- 
ments  described  in  Tables I  and  II,  showing  the  specificity of  the  effect of 
vinblastine on SRBC-stimulated T  cells and B  cells. 
Another possibility was that the effect of vinblastine on T  cells and B  cells 
may not reflect a difference in the kinetics of proliferation, if the proliferating T 
cells are preferentially resistant to the action of vinblastine for at least  1 day. 
We  are unaware  of any evidence  to  support  this  possibility and  consider  it 
highly unlikely, although it cannot be eliminated in a strict sense on the basis of 
the data presented here. 
Our results are in marked contrast to those of Segal et al. (23), who reported 
that the priming of helper activity to rabbit serum albumin in mice is sensitive 
to vinblastine only during the first 24 h, a time when we have seen no sensitivity 
even to high doses of vinblastine in  the priming of helper activity to SRBC. 
These differences in our results are not at present resolved. 
Our results are, however, in general agreement with the work of Byfield and 
Sercarz  (9),  who  describe  the  existence  of  what  they  call  "quick response" 
memory in the spleens of mice primed with SRBC. This memory, seen between 
1 and 10 days after priming, is most likely due to helper T  cell stimulation, since 
it occurs at low priming doses which have been shown by others to be preferen- 
tial for T  cells (12,  14, 24). The establishment of this memory is sensitive to the 
inhibitors of DNA synthesis, methotrexate, and hydroxyurea, particularly be- 
tween days 1 and 4 after priming. 
There are other reports of the rapid proliferation of T  cells in  response to 
stimulation  with  SRBC.  Davies  et  al.  (25,  26)  performed experiments  with 
adult  thymectomized  mice  which  were  irradiated,  reconstituted  with  bone 
marrow, and grafted with a thymus lobe from mice bearing the T6T6 chromo- 
somal marker. They demonstrated that a sizable proportion of the mitotic cells 
found in the spleens of these animals after immunization with SRBC  were of 
the thymus graft origin, with the peak of the proliferative response coming 3 
days after the antigen was administered. 
A number of workers have shown the presence of helper activity in the spleens 
of irradiated mice which have been reconstituted with thymus cells and SRBC 
(27-29).  The development of this activity, sometimes referred to as "thymus 
education" has been shown by Ito and Cudkowicz (30)  to be sensitive to vin- 
blastine during day 1 and day 2 after reconstitution. Whether or not these re- 
sults can be compared to those obtained with priming is unclear, since thymus 
education differs from priming in a number of properties, such as the kinetics JOHN  W.  KAPPLER  AND  MICHAEL  HOFFMANN  1333 
of the appearance of helper activity, the dose of antigen required, and perhaps 
the stage of differentiation of the stimulated cells. 
Mishell and Dutton (3) have demonstrated that the precursors of anti-SRBC 
PFC are maximally sensitive to high doses of tritiated thymidine (specifically 
lethal to cells synthesizing DNA)  between  1 and 2 days after stimulation in 
vitro with SRBC. On the other hand a large number of workers (31, 32, for re- 
views see 33, 34) have shown that T  cells populations stimulated in vitro with 
mitogens or antigens show their maximal proliferative response about 3 days 
later, again indicating a difference in the kinetics of the response of the two cell 
types. 
The demonstration that in the primary response to SRBC,  T  cells lag  at 
least 1 day behind B cells in the onset of cellular proliferation, leads to the ques- 
tion of the nature of the T cell which has been demonstrated to participate in the 
initiation of the primary B cell response. Our data would suggest either that the 
T  cell which initiates the primary response does so before proliferating or that 
there are two populations of T  cells involved. This second possibility has been 
suggested by Raft and Cantor (35) in a recent study indicating the presence of 
two subpopulations of T  cells in mice. Although the evidence is incomplete, a 
model emerges which can be used to interpret the data. One subpopulation, T1, 
is relatively immature and is preferentially found in the spleen. These cells do 
not recirculate and are not removed by thoracic duct drainage. T1 cells are ap- 
parently shorflived and of recent thymus origin in that they disappear from the 
animal within 2 to 6 wk after adult thymectomy. The other population of T 
cells, T2, is more mature and found preferentially in the circulation and lymph 
nodes. They recirculate and are removed by thoracic duct drainage. T2 cells are 
long-lived, being detectable in the animal 30 wk after thymectomy. Raft and 
Cantor (35) propose that priming is the antigen-driven proliferation and differ- 
entiation of T1 cells to T2 cells which are the active helper T cells. The primary 
B cell response is considered to be initiated by a few preexisting T2 cells which 
arise during the development of the animal through the stimulation of T1 cells 
by environmental antigens which cross-react with SRBC. Our data is consistent 
with this model. 
Raft and Cantor  (35)  predict that adult thymectomy should affect mainly 
those T  cell functions requiring T  cell priming, but not the primary B  cell re- 
sponse. We have preliminary evidence that this is indeed the case.  2  Whereas, the 
in vivo and in vitro primary responses ro SRBC are normal up to 15 wk after 
adult thymectomy, the ability to prime T cells for helper activity or for delayed 
hypersensitivity decreases rapidly within a few weeks. The better understand- 
ing of these observations will have to await further evidence on the nature and 
the relation between these two T cell populations. 
The data in Figs. 1 and 3 indicate that although helper T cells are undergoing 
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rapid division between day 3  and day 4  after immunization,  there is no sub- 
stantial  increase in  the  concentration  of helper  activity in  the  spleen  during 
this time. This observation might be explained by the saturation of the spleen 
with primed T: cells by day 3, followed by the exit of excess cells.  Consistent 
with this interpretation is the work of Sprent et al. (16), who have demonstrated 
that T cells leave the circulation (and presumably lodge in the spleen and lymph 
nodes)  shortly after immunization with  SRBC,  but return  in  increased num- 
bers between day 3 and day 5. 
Recent evidence has shown that a number of manipulations can lead prefer- 
entially  to  a  cellular  rather  than  a  humoral  immune  response. Low doses of 
antigen  (12,  14,  24),  chemically modified  antigens  (36,  37),  antigens  which 
cross-react at the T  cell level only (18,  3840),  and antigens given in the pres- 
ence of passively administered antiserum (12,  15) have all been used to initiate 
a  T  cell response in the absence of significant antibody production.  Our data 
indicate  yet another method.  The proper  selection of the dose of vinblastine 
and the timing of administration leads to a normal T  cell response to SRBC in 
the virtual absence of antibody production (Fig. 3). These techniques may yet 
prove useful in clinical situations, such as cases involving certain cancers where 
the production of "blocking antibody" can interfere with the successful T  cell- 
mediated rejection of a tumor (41). 
SU2~IMARY 
The kinetics of the in vivo response to SRBC was studied in mouse spleen at 
both the B  cell and T  cell levels. The B  cell response was assayed by following 
the  appearance  of antibody-secreting  cells  in  the  spleen  using  the hemolytic 
plaque assay. The T  cell response was monitored by following the increase in or 
"priming" of helper activity in the spleen using a  quantitative in vitro assay. 
The role of cellular proliferation in both responses was established with the in- 
hibitor of mitosis, vinblastine. 
The results show that, although the development of T  cell  activity precedes 
that of anti-SRBC PFC by as much as 1 day, T  cells lag at least 1 day behind B 
cells in the onset of cellular proliferation. 
The evidence suggests either that the  helper  T  cell  which  proliferates in re- 
sponse to SRBC does so after helping in the initiation of the primary B  cell re- 
sponse or that the proliferative T cell response and the initiation of the primary 
B cell response involve two different subpopulations of T  cells. 
This study was performed in the laboratory of Dr. Richard W. Dutton whose encourage- 
ment is gratefully acknowledged.  We  also  wish to  thank  Ms.  Mildred  Davenport and  Ms. 
Sara Albanil for their technical assistance. 
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